OTCMKTS:MAMP Medamerica Properties (MAMP) Stock Price, News & Analysis $3.07 +0.32 (+11.64%) As of 12/27/2019 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Medamerica Properties Stock (OTCMKTS:MAMP) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Medamerica Properties alerts:Sign Up Key Stats Today's Range$2.75▼$3.0750-Day Range$3.07▼$3.0752-Week Range$1.90▼$6.00Volume300 shsAverage Volume276 shsMarket Capitalization$8.01 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview MedAmerica Properties Inc., a real estate management company, focuses on investing in commercial real estate properties in the United States. It focuses to acquire medical office buildings. The company was formerly known as Banyan Rail Services Inc. and changed its name to MedAmerica Properties Inc. in June 2017. MedAmerica Properties Inc. was founded in 1985 and is based in Boca Raton, Florida. Read More Receive MAMP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medamerica Properties and its competitors with MarketBeat's FREE daily newsletter. Email Address MAMP Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com MAMP Stock Analysis - Frequently Asked Questions How have MAMP shares performed this year? Medamerica Properties' stock was trading at $3.07 at the beginning of the year. Since then, MAMP shares have increased by 0.0% and is now trading at $3.07. How do I buy shares of Medamerica Properties? Shares of MAMP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Medamerica Properties own? Based on aggregate information from My MarketBeat watchlists, some other companies that Medamerica Properties investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX) and Ampio Pharmaceuticals (AMPE). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorFinance Industry Sanitary Services Sub-IndustryReal Estate Current SymbolOTCMKTS:MAMP Previous SymbolOTCMKTS:BARA CIK764897 Webwww.medamericaproperties.com Phone561-617-8050FaxN/AEmployees40Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$600 thousand Net MarginsN/A Pretax MarginN/A Return on Equity-398.90% Return on Assets-445.23% Debt Debt-to-Equity RatioN/A Current Ratio0.15 Quick Ratio0.15 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.01 per share Price / Book307.00Miscellaneous Outstanding Shares2,610,000Free FloatN/AMarket Cap$8.01 million OptionableNot Optionable Beta-2.54 7 Stocks to Ride The A.I. MegaboomWe are about to experience the greatest A.I. boom in stock market history... Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s. That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom. Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day. And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly... Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy. Get This Free Report This page (OTCMKTS:MAMP) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medamerica Properties Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Medamerica Properties With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access